Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Sarcoma × Adjuvants, Immunologic × Clear all

Status

Sponsor Class

Study Type

Observational 1 Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma 1 Multiple Myeloma 1

Interventions

Gene Expression Profiling 8 Surgical Procedures, Operative 6 Surveys and Questionnaires 5 Polymerase Chain Reaction 5 Blood Specimen Collection 5 Microarray Analysis 4 Immunohistochemistry 4 Base Sequence 4 Trabectedin 3 Therapeutics 3 Reverse Transcriptase Polymerase Chain Reaction 3 Radiation 3 Observation 3 Radiotherapy 2 Psychiatric Rehabilitation 2 Methods 2 In Situ Hybridization, Fluorescence 2 Gene Rearrangement 2 Drug Therapy 2 DNA Methylation 2 Amplified Fragment Length Polymorphism Analysis 2 trastuzumab deruxtecan 1 pazopanib 1 liposomal doxorubicin 1 fluorodopa F 18 1 eribulin 1 Watchful Waiting 1 Transurethral Resection of Bladder 1 Ropivacaine 1 Referral and Consultation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03978039 2025-09-04

BCB-Sarcomes

Institut Bergonié

150,000 enrolled

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡